Previous 10 | Next 10 |
2024-05-23 09:58:25 ET Summary Bristol Myers Squibb shares have plummeted due to concerns about patent expirations and growth prospects. BMY stock is currently trading near its 200-week moving average, which historically has been a good buying opportunity. The company has made...
Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a low incidence rate of extrapyramidal symptoms was reported over long-term trials in adults with schizophrenia In-trial qualitative interviews found t...
2024-05-22 16:29:53 ET Summary Today, we take a more in-depth look at drug giant Pfizer Inc., which has experienced falling revenues as Covid-19 has become endemic. The acquisition of Seagen did add blockbuster oncology therapies to Pfizer's portfolio, boosting sagging oncology sa...
2024-05-22 16:22:24 ET Bristol-Myers Squibb ( NYSE: BMY ) shares traded in the green on Tuesday, breaking six straight days of losses. Stock closed up 0.17% at $42.34.... Read the full article on Seeking Alpha For further details see: Bristol-Myers Squibb snaps six d...
2024-05-22 15:38:02 ET More on Bristol-Myers, Sanofi, etc. Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript) Brist...
The Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo ™ in select countries Bristol Myers Squibb (NYSE: BMY) today announced ASPIRE (Accessibility, Sustainability, Patient-centr...
2024-05-21 10:00:00 ET Summary Pfizer shares have lagged behind the pharma rally due to inflated expectations, one-time losses, write-offs, and the Seagen acquisition. The company is expecting an LOE wave with 6 names facing patent expirations, leading to a $17 billion sales decli...
The national initiative, Live Your PosSCZible, is focused on elevating the voices of those with schizophrenia and their care partners to drive impactful conversations about the aspirations of the community Actor and author Taye Diggs and his sister, Christian, who was diagnosed with s...
2024-05-21 08:15:06 ET Citigroup analyst issues BUY recommendation for BMY on May 21, 2024 06:22AM ET. The previous analyst recommendation was Buy. BMY was trading at $43.36 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...
2024-05-21 08:15:00 ET There are many positive things about Bristol Myers Squibb (NYSE: BMY) and its stock. It has a decently high dividend yield, it's one of the world's largest pharmaceutical companies, and it makes dozens and dozens of life-saving medications, with even more to c...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
Bristol-Myers Squibb Company Website:
NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb Company Our Approach to ESG At BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development a...
The Application is based on Phase 3 CheckMate - 9DW trial results demonstrating improved survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib in this patient population Bristol Myers Squibb (NYSE: ...
SBTi validation affirms BMS' long-standing commitment to environmental stewardship PRINCETON, NJ / ACCESSWIRE / July 18, 2024 / Bristol Myers Squibb (NYSE:BMY) today announced validation for its near-term and net-zero science-based targets from the Science Based Targets initiative (SBTi), ...